Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

by | Jan 1, 2021 | Publicaciones - CIMO-02 | 0 comments

Lee, NY; Ferris, RL; Psyrri, A; Haddad, RI; Tahara, M; Bourhis, J; Harrington, K; Chang, PMH; Lin, JC; Razaq, MA; Teixeira, MM; Lovey, J; Chamois, J; Rueda, A; Hu, CS; Dunn, LA; Dvorkin, MV; De Beukelaer, S; Pavlov, D; Thurm, H; Cohen, E – 2021